Women more likely to return for additional imaging only, short-interval follow-up, or biopsy after true-negative result<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Sept. 4, 2024 (HealthDay News) — Women are less likely to return for subsequent screening after false-positive mammography results, according to a study published online Sept. 3 in the Annals of Internal Medicine<\/em>.<\/p>\n Diana L. Miglioretti, Ph.D., from the University of California in Davis, and colleagues examined the association between screening mammography results and the probability of subsequent screening in a cohort study involving 3,529,825 screening mammograms (3,184,482 true negatives and 345,343 false positives) performed from 2005 to 2017 among 1,053,672 women aged 40 to 73 years.<\/p>\n The researchers found that the likelihood of returning was higher after a true-negative result than after a false-positive recall for additional imaging only, short-interval follow-up, or biopsy (adjusted absolute difference, \u00e2\u0088\u00921.9, \u00e2\u0088\u009215.9, and \u00e2\u0088\u009210.0 percentage points, respectively). The largest decreases in the probability of returning after a false positive versus a true negative were seen for Asian and Hispanic\/Latino women for short-interval follow-up or biopsy (\u00e2\u0088\u009220 to \u00e2\u0088\u009225 points and \u00e2\u0088\u009213 to \u00e2\u0088\u009214 points, respectively). A false-positive result on the second of two screening mammograms within five years was associated with a reduced probability of returning for a third, irrespective of the first screening result.<\/p>\n “Physicians should educate their patients about the importance of continued screening after false-positive results, especially given the associated increased future risk for breast cancer,” the authors write.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n